7‐Iodo‐8‐aza‐7‐deaza‐2′‐deoxy­adenosine and 7‐bromo‐8‐aza‐7‐deaza‐2′‐deoxyadenosine

The isomorphous structures of the title molecules, 4‐amino‐1‐(2‐deoxy‐β‐d ‐erythro‐pento­furan­osyl)‐3‐iodo‐1H‐pyrazolo‐[3,4‐d]pyrimidine, (I), C₁₀H₁₂IN₅O₃, and 4‐amino‐3‐bromo‐1‐(2‐deoxy‐β‐d ‐erythro‐pento­furan­osyl)‐1H‐pyrazolo[3,4‐d]­pyrimidine, (II), C₁₀H₁₂BrN₅O₃, have been determined. The sugar puckering of both compounds is C1′‐endo (^1′E). The N‐­glycosidic bond torsion angle χ¹ is in the high‐anti range [?73.2 (4)° for (I) and ?74.1 (4)° for (II)] and the crystal structure is stabilized by hydrogen bonds.     

2′‐Deoxy‐5‐methylisocytidine

In the title compound, 2‐amino‐1‐(2‐deoxy‐β‐d ‐erythro‐pento­furan­osyl)‐5‐methyl­pyrimidin‐4(1H)‐one, C₁₀H₁₅N₃O₄, the conformation of the N‐glycosidic bond is syn and the 2‐deoxy­ribo­furan­ose moiety adopts an unusual ^OT₁ sugar pucker. The orientation of the exocyclic C4′—C5′ bond is +sc (+gauche).     

Regioisomeric 4‐nitroindazole N1‐ and N2‐(β‐d‐ribonucleosides)

The structures of the isomeric nucleosides 4‐nitro‐1‐(β‐d ‐ribo­furan­osyl)‐1H‐indazole, C₁₂H₁₃N₃O₆, (I), and 4‐nitro‐2‐(β‐d ‐ribo­furan­osyl)‐2H‐indazole, C₁₂H₁₃N₃O₆, (II), have been determined. For compound (I), the conformation of the gly­cosylic bond is anti [χ = −93.6 (6)°] and the sugar puckering is C2′‐exo–C3′‐endo. Compound (II) shows two conformations in the crystalline state which differ mainly in the sugar pucker; type 1 adopts the C2′‐endo–C3′‐exo sugar puckering associated with a syn base orientation [χ = 43.7 (6)°] and type 2 shows C2′‐exo–C3′‐endo sugar puckering accompanied by a somewhat different syn base orientation [χ = 13.8 (6)°].     

The high‐anti conformation of 8‐aza‐1,3‐dide­aza‐2′‐deoxy­adenosine

In the title compound, 4‐amino‐1‐(2‐deoxy‐β‐d ‐erythro‐pento­furan­osyl)‐1H‐benzotriazole, C₁₁H₁₄N₄O₃, the conformation of the N‐glycosidic bond is in the high‐anti range [χ = ?77.1 (4)°] and the 2′‐deoxy­ribo­furan­ose moiety adopts a 2′‐­endo (²E) sugar puckering. The 5′‐hydroxyl group is disordered and has conformations ap with γ = 171.1 (3)° [occupation of 61.4 (3)%] and +sc with γ = 52.4 (6)° [occupation of 38.6 (3)%]. The nucleobases are stacked in the crystal state.     

7‐Vinyl‐8‐aza‐7‐de­aza‐2′‐deoxy­adenosine monohydrate

In the title compound, 4‐amino‐1‐(2‐deoxy‐β‐d ‐eythro‐pento­furan­osyl)‐3‐vinyl‐1H‐pyrazolo­[3,4‐d]­pyrimidine monohydrate, C₁₂H₁₅N₅O₃·H₂O, the conformation of the gly­cosyl bond is anti. The furan­ose moiety is in an S conformation with an unsymmetrical twist, and the conformation at the exocyclic C—C(OH) bond is +sc (gauche, gauche). The vinyl side chain is bent out of the heterocyclic ring plane by 147.5 (5)°. The three‐dimensional packing is stabilized by O—H·O, O—H·N and N—H·O hydrogen bonds.     

The α‐d anomer of 5‐aza‐7‐deaza‐2′‐deoxyguanosine

In the monohydrate of 2‐amino‐8‐(2‐deoxy‐α‐d ‐erythro‐pento­furan­osyl)‐8H‐imidazo­[1,2‐a]­[1,3,5]­triazin‐4‐one, C₁₀H₁₃N₅O₄·H₂O, denoted (I) or αZ_d, the conformation of the N‐gly­cosyl­ic bond is in the high‐anti range [χ = 87.5 (3)°]. The 2′‐deoxy­ribo­furan­ose moiety adopts a C2′‐endo,C3′‐exo(^2′T_3′) sugar puckering (S‐type sugar) and the conformation at the C4′—C5′ bond is ?sc (trans).     

5‐Methyl‐6‐aza‐2′‐deoxy­isocytidine

In the title compound, 3‐amino‐2‐(2‐deoxy‐β‐d ‐erythro‐pento­furan­osyl)‐6‐methyl‐1,2,4‐triazin‐5(2H)‐one, C₉H₁₄N₄O₄, the conformation of the N‐glycosidic bond is high‐anti and the 2‐deoxy­ribo­furan­osyl moiety adopts a North sugar pucker (²T₃). The orientation of the exocyclic C—C bond between the –CH₂OH group and the five‐membered ring is ap (gauche, trans). The crystal packing is such that the nucleobases lie parallel to the ac plane; the planes are connected via hydrogen bonds involving the five‐membered ring.     

4,1′,6′‐Trichloro‐4,1′,6′‐trideoxysucrose monohydrate

At 160 K, the gluco­pyran­osyl ring in 1,6‐di­chloro‐1,6‐di­deoxy‐β‐d ‐fructo­furan­osyl 4‐chloro‐4‐deoxy‐α‐d ‐gluco­pyran­oside monohydrate, C₁₂H₁₉Cl₃O₈·H₂O, has a near ideal ⁴C₁ chair conformation, while the fructo­furan­osyl ring has a ⁴T₃ conformation. The conformation of the sugar mol­ecule is quite different to that of sucralose, particularly in the conformation about the glycosidic linkage, which affects the observed pattern of intramolecular hydrogen bonds. A complex series of intermolecular hydrogen bonds links the sugar and water mol­ecules into an infinite three‐dimensional framework.     

2′,3′‐Dide­hydro‐3′‐deoxy­thymidine N‐methyl‐2‐pyrrolidone solvate (D4T·NMPO)

The title compound, 1‐(2′,3′‐di­deoxy‐β‐d ‐glycero‐pent‐2‐eno­furan­osyl)­thymine 1‐methyl‐2‐pyrrolidone solvate, C₁₀H₁₂N₂O₄·­C₅H₉NO, is an NMPO solvate of the anti‐AIDS agent D4T. In its crystal structure, both the pyrimidine and the furan­ose rings are planar and approximately perpendicular [82.1 (4)°]. The value of the torsion angle defining the orientation of the thymine with respect to the joined furane, χ = ?100.8 (4)°, and that of the torsion angle giving the orientation of the hydroxyl group linked to the furane ring, γ = 52.9 (5)°, show that the gly­cosyl­ic link adopts the so‐called high‐anti conformation and the 5′‐hydroxyl group is in the +sc position. The NMPO solvate is linked to the nucleoside through a fairly strong hydrogen bond.     

2,3,3′,6‐Tetra‐O‐acetyl‐4,1′,6′‐trichloro‐4,1′,4′,6′‐tetradeoxygalactosucrose

At 160 K, one of the Cl atoms in the furanoid moiety of 3‐O‐acetyl‐1,6‐di­chloro‐1,4,6‐tri­deoxy‐β‐d ‐fructo­furan­osyl 2,3,6‐tri‐O‐acetyl‐4‐chloro‐4‐deoxy‐α‐d ‐galacto­pyran­oside, C₂₀H₂₇­Cl₃O₁₁, is disordered over two orientations, which differ by a rotation of about 107° about the parent C—C bond. The conformation of the core of the mol­ecule is very similar to that of 3‐O‐acetyl‐1,4,6‐tri­chloro‐1,4,6‐tri­deoxy‐β‐d ‐tagato­furanos­yl 2,3,6‐tri‐O‐acetyl‐4‐chloro‐4‐deoxy‐α‐d ‐galacto­pyran­oside, particularly with regard to the conformation about the glycosidic linkage.     

1,N6‐Etheno derivative of 7‐de­aza‐2,8‐di­aza­adenosine

In the tricyclic nucleoside 7‐(β‐d ‐ribo­furan­osyl)‐7H‐imidazo­[1,2‐c]­pyrazolo­[4,3‐e][1,2,3]­triazine, C₁₁H₁₂N₆O₄, the con­formation of the N‐gly­cosyl bond is intermediate between anti and high anti [χ = −103.5 (3)°]. The ribo­furan­ose moiety adopts a ₃T² sugar pucker (S‐type sugar) and the conformation at the exocyclic C—C bond is ap (gauche–trans). Molecules of the title compound form a three‐dimensional network via three medium–strong intermolecular hydrogen bonds (one O—H⋯N and two O—H⋯O bonds).     

7‐Deaza‐2′‐deoxy­guanosine

In the title compound, 2‐amino‐7‐(2‐deoxy‐β‐d ‐erythro‐pentofuran­osyl)‐3,7‐dihydro­pyrrolo[2,3‐d]pyrimidin‐4‐one, C₁₁H₁₄N₄O₄, the N‐glycosylic bond torsion angle, χ, is anti [−106.5 (3)°]. The 2′‐deoxy­ribofuran­osyl moiety adopts the ³T₄ (N‐type) conformation, with P = 39.1° and τ_m = 40.3°. The conformation around the exocyclic C—C bond is ap (trans), with a torsion angle, γ, of −173.8 (3)°. The nucleoside forms a hydrogen‐bonded network, leading to a close‐packed multiple‐layer structure with a head‐to‐head arrangement of the bases. The nucleobase interplanar O=C—C⋯NH₂ distance is 3.441 (1) Å.     

Solid‐state transformation of 4,2′‐an­hydro‐5‐(β‐d‐arabino­furan­osyl)­uracil dihydrate to 4,2′‐an­hydro‐5‐(β‐d‐arabino­furan­osyl)­uracil mono­hydrate

Crystals of 4,2′‐an­hydro‐5‐(β‐d ‐arabino­furan­osyl)­uracil, (I), obtained from an aqueous solution, were characterized as the dihydrate, C₉H₁₀N₂O₅·2H₂O, (Ia). In air, these crystals slowly transform to the mono­hydrate, C₉H₁₀N₂O₅·H₂O, (Ib), but remain crystalline. The solid‐state transformation proceeds with the loss of one water mol­ecule and a rearrangement of hydrogen‐bonded layers of mol­ecules. The furan­ose ring in (I) has an approximate C4′‐exo,O4′‐endo twist conformation. The central five‐membered ring is slightly puckered. The uracil group is planar within experimental uncertainty.     

8‐Aza‐7‐deaza‐2′‐de­oxy‐2‐(methyl­sulfan­yl)adenosine

In the title compound, 4‐amino‐1‐(2‐de­oxy‐β‐d ‐erythro‐pentofuranos­yl)‐6‐methyl­sulfanyl‐1H‐pyrazolo[3,4‐d]pyrimidine, C₁₁H₁₆N₅O₃S, the conformation of the glycosidic bond is between anti and high anti. The 2′‐deoxy­ribofuranosyl moiety adopts the C3′‐exo–C4′‐endo conformation (₃T⁴, S‐type sugar pucker), and the conformation at the exocyclic C—C bond is +sc (+gauche). The exocyclic 6‐amine group and the 2‐methyl­sulfanyl group lie on different sides of the heterocyclic ring system. The mol­ecules form a three‐dimensional hydrogen‐bonded network that is stabilized by O—H⋯N, N—H⋯O and C—H⋯O hydrogen bonds.     

6‐Aza‐2′‐deoxy­uridine and N3‐anisoyl‐6‐aza‐2′‐deoxy­uridine

In 2‐(2‐deoxy‐β‐d ‐erythro‐pentofuranosyl)‐1,2,4‐triazine‐3,5(2H,4H)‐dione (6‐aza‐2′‐deoxy­uridine), C₈H₁₁N₃O₅, (I), the conformation of the glycosylic bond is between anti and high‐anti [χ = −94.0 (3)°], whereas the derivative 2‐(2‐deoxy‐β‐d ‐erythro‐pentofuranosyl)‐N⁴‐(2‐methoxy­benzoyl)‐1,2,4‐triazine‐3,5(2H,4H)‐dione (N³‐anisoyl‐6‐aza‐2′‐deoxy­uridine), C₁₆H₁₇N₃O₇, (II), displays a high‐anti conformation [χ = −86.4 (3)°]. The furanosyl moiety in (I) adopts the S‐type sugar pucker (²T₃), with P = 188.1 (2)° and τ_m = 40.3 (2)°, while the sugar pucker in (II) is N (³T₄), with P = 36.1 (3)° and τ_m = 33.5 (2)°. The crystal structures of (I) and (II) are stabilized by inter­molecular N—H⋯O and O—H⋯O inter­actions.     

1‐(β‐d‐Erythrofuranos­yl)cytidine (β‐erythrocytidine)

1‐(β‐d ‐Erythrofuranosyl)cytidine, C₈H₁₁N₃O₄, (I), a derivative of β‐cytidine, (II), lacks an exocyclic hydroxy­methyl (–CH₂OH) substituent at C4′ and crystallizes in a global conformation different from that observed for (II). In (I), the β‐d ‐erythrofuranosyl ring assumes an E₃ conformation (C3′‐exo; S, i.e. south), and the N‐glycoside bond conformation is syn. In contrast, (II) contains a β‐d ‐ribofuranosyl ring in a ³T₂ conformation (N, i.e. north) and an anti‐N‐glycoside linkage. These crystallographic properties mimic those found in aqueous solution by NMR with respect to furan­ose conformation. Removal of the –CH₂OH group thus affects the global conformation of the aldofuranosyl ring. These results provide further support for S/syn–anti and N/anti correlations in pyrimidine nucleosides. The crystal structure of (I) was determined at 200 K.     

6‐Aza‐2′‐deoxy‐2′‐arabino­fluoro­uridine,a 2′‐deoxy­ribonucleoside with an N‐sugar conformation in the solid state and in solution

In the title compound, 2‐(2‐deoxy‐2‐fluoro‐β‐d ‐arabino­fur­anosyl)‐1,2,4‐triazine‐3,5(2H,4H)‐dione, C₈H₁₀FN₃O₅, the torsion angle of the N‐gly­cosylic bond is anti [χ = −125.37 (13)°]. The furan­ose moiety adopts the N‐type sugar pucker (³T₂), with P = 359.2° and τ_m = 31.4°. The conformation around the C4′—C5′ bond is antiperiplanar (trans), with a torsion angle γ of 177.00 (11)°. A network is formed via hydrogen bonds from the nucleobases to the sugar residues, as well as through hydrogen bonds between the sugar moieties.     

2‐Amino‐7‐chloro‐2′‐deoxy­tubercidin

In 4‐chloro‐7‐(2‐de­oxy‐β‐d ‐erythro‐pento­furanos­yl)‐7H‐pyr­rolo­[2,3‐d]­pyrimidine‐2,4‐diamine, C₁₁H₁₄ClN₅O₃, the conformation of the N‐glycosylic bond is between anti and high‐anti [χ = −102.5 (6)°]. The 2′‐deoxy­ribofuranosyl unit adopts the C3′‐endo‐C4′‐exo (³T₄) sugar pucker (N‐type) with P = 19.6° and τ_m = 32.9° [terminology: Saenger (1989). Landolt‐Börnstein New Series, Vol. 1, Nucleic Acids, Subvol. a, edited by O. Madelung, pp. 1–21. Berlin: Springer‐Verlag]. The orientation of the exocyclic C4′—C5′ bond is +ap (trans) with a torsion angle γ = 171.5 (4)°. The compound forms a three‐dimensional network that is stabilized by four inter­molecular hydrogen bonds (N—H⋯O and O—H⋯N) and one intra­molecular hydrogen bond (N—H⋯Cl).     

(2S)‐2‐[1‐(2,4‐Di­fluoro‐5‐iodo­phenyl)‐2‐deoxy‐β‐d‐ribo­furanos‐5‐yloxy]‐8‐methyl‐4H‐1,3,2‐benzodioxa­phosphole 2‐oxide

The title compound, C₁₉H₁₈F₂IO₆P, prepared as a potential antiviral and anticancer agent from 3‐methyl­salicyl­chloro­phosphane and 1‐(2,4‐di­fluoro‐5‐iodo­phenyl)‐2‐deoxy‐β‐d ‐ribo­furan­ose, is one of a 1:1 mixture of two diastereomers. The diastereomers differ in their configuration, S or R, at the asymmetric phosphorus center. X‐Ray crystallographic analysis of the title compound has determined the absolute configuration at the asymmetric P center to be S.     

2′‐Deoxy‐5‐propynyluridine: a nucleoside with two conformations in the asymmetric unit

The title compound, 1‐(2‐deoxy‐β‐d ‐erythro‐pentofuranosyl)‐5‐(prop‐1‐ynyl)pyrimidin‐2,4(1H,3H)‐dione, C₁₂H₁₄N₂O₅, shows two conformations in the crystalline state: conformer 1 adopts a C2′‐endo (close to ²E; S‐type) sugar pucker and an anti nucleobase orientation [χ = −134.04 (19)°], while conformer 2 shows an S sugar pucker (twisted C2′‐endo–C3′‐exo), which is accompanied by a different anti base orientation [χ = −162.79 (17)°]. Both molecules show a +sc (gauche, gauche) conformation at the exocyclic C4′—C5′ bond and a coplanar orientation of the propynyl group with respect to the pyrimidine ring. The extended structure is a three‐dimensional hydrogen‐bond network involving intermolecular N—H...O and O—H...O hydrogen bonds. Only O atoms function as H‐atom acceptor sites.